nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Cladribine—NR5A1—ovarian cancer	0.0329	1	CrCbGaD
Entecavir—Laboratory test abnormal—Epirubicin—ovarian cancer	0.00921	0.00952	CcSEcCtD
Entecavir—Infection—Carboplatin—ovarian cancer	0.00905	0.00936	CcSEcCtD
Entecavir—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00877	0.00907	CcSEcCtD
Entecavir—Dizziness—Altretamine—ovarian cancer	0.00872	0.00902	CcSEcCtD
Entecavir—Laboratory test abnormal—Doxorubicin—ovarian cancer	0.00852	0.00881	CcSEcCtD
Entecavir—Ascites—Epirubicin—ovarian cancer	0.00847	0.00875	CcSEcCtD
Entecavir—Vomiting—Altretamine—ovarian cancer	0.00839	0.00867	CcSEcCtD
Entecavir—Hepatic failure—Vinorelbine—ovarian cancer	0.00808	0.00836	CcSEcCtD
Entecavir—Nausea—Altretamine—ovarian cancer	0.00783	0.0081	CcSEcCtD
Entecavir—Ascites—Doxorubicin—ovarian cancer	0.00783	0.0081	CcSEcCtD
Entecavir—Neutropenia—Chlorambucil—ovarian cancer	0.00771	0.00797	CcSEcCtD
Entecavir—Body temperature increased—Carboplatin—ovarian cancer	0.0072	0.00745	CcSEcCtD
Entecavir—Neutropenia—Topotecan—ovarian cancer	0.00686	0.0071	CcSEcCtD
Entecavir—Blood creatinine increased—Vinorelbine—ovarian cancer	0.0068	0.00704	CcSEcCtD
Entecavir—Neutropenia—Melphalan—ovarian cancer	0.00672	0.00695	CcSEcCtD
Entecavir—Transaminases increased—Epirubicin—ovarian cancer	0.00632	0.00654	CcSEcCtD
Entecavir—Serum creatinine increased—Epirubicin—ovarian cancer	0.00625	0.00647	CcSEcCtD
Entecavir—Hepatobiliary disease—Topotecan—ovarian cancer	0.00619	0.0064	CcSEcCtD
Entecavir—Pancreatitis—Vinorelbine—ovarian cancer	0.00615	0.00636	CcSEcCtD
Entecavir—Hepatobiliary disease—Melphalan—ovarian cancer	0.00606	0.00627	CcSEcCtD
Entecavir—Neutropenia—Vinorelbine—ovarian cancer	0.00587	0.00607	CcSEcCtD
Entecavir—Transaminases increased—Doxorubicin—ovarian cancer	0.00585	0.00605	CcSEcCtD
Entecavir—Alopecia—Chlorambucil—ovarian cancer	0.00583	0.00603	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—ovarian cancer	0.00579	0.00598	CcSEcCtD
Entecavir—Hepatitis—Melphalan—ovarian cancer	0.00575	0.00595	CcSEcCtD
Entecavir—Hepatomegaly—Epirubicin—ovarian cancer	0.00544	0.00562	CcSEcCtD
Entecavir—Immune system disorder—Topotecan—ovarian cancer	0.00531	0.00549	CcSEcCtD
Entecavir—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.00529	0.00547	CcSEcCtD
Entecavir—Immune system disorder—Melphalan—ovarian cancer	0.00519	0.00537	CcSEcCtD
Entecavir—Alopecia—Topotecan—ovarian cancer	0.00519	0.00537	CcSEcCtD
Entecavir—Leukopenia—Chlorambucil—ovarian cancer	0.00514	0.00532	CcSEcCtD
Entecavir—Malnutrition—Topotecan—ovarian cancer	0.00511	0.00529	CcSEcCtD
Entecavir—Alopecia—Melphalan—ovarian cancer	0.00508	0.00526	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—ovarian cancer	0.00503	0.0052	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—ovarian cancer	0.00475	0.00491	CcSEcCtD
Entecavir—Infection—Chlorambucil—ovarian cancer	0.00466	0.00482	CcSEcCtD
Entecavir—Hepatic failure—Docetaxel—ovarian cancer	0.00461	0.00476	CcSEcCtD
Entecavir—Leukopenia—Topotecan—ovarian cancer	0.00458	0.00473	CcSEcCtD
Entecavir—Blood creatinine increased—Paclitaxel—ovarian cancer	0.00458	0.00473	CcSEcCtD
Entecavir—Immune system disorder—Vinorelbine—ovarian cancer	0.00454	0.00469	CcSEcCtD
Entecavir—Leukopenia—Melphalan—ovarian cancer	0.00448	0.00463	CcSEcCtD
Entecavir—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00446	0.00461	CcSEcCtD
Entecavir—Alopecia—Vinorelbine—ovarian cancer	0.00444	0.00459	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—ovarian cancer	0.00439	0.00454	CcSEcCtD
Entecavir—Malnutrition—Vinorelbine—ovarian cancer	0.00437	0.00452	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00432	0.00447	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00423	0.00438	CcSEcCtD
Entecavir—Anaphylactic shock—Topotecan—ovarian cancer	0.00417	0.00431	CcSEcCtD
Entecavir—Infection—Topotecan—ovarian cancer	0.00415	0.00429	CcSEcCtD
Entecavir—Pancreatitis—Paclitaxel—ovarian cancer	0.00414	0.00428	CcSEcCtD
Entecavir—Dyspepsia—Chlorambucil—ovarian cancer	0.00413	0.00427	CcSEcCtD
Entecavir—Nervous system disorder—Topotecan—ovarian cancer	0.00409	0.00423	CcSEcCtD
Entecavir—Anaphylactic shock—Melphalan—ovarian cancer	0.00409	0.00423	CcSEcCtD
Entecavir—Infection—Melphalan—ovarian cancer	0.00406	0.0042	CcSEcCtD
Entecavir—Skin disorder—Topotecan—ovarian cancer	0.00405	0.00419	CcSEcCtD
Entecavir—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00405	0.00418	CcSEcCtD
Entecavir—Fatigue—Chlorambucil—ovarian cancer	0.00404	0.00418	CcSEcCtD
Entecavir—Skin disorder—Melphalan—ovarian cancer	0.00397	0.0041	CcSEcCtD
Entecavir—Neutropenia—Paclitaxel—ovarian cancer	0.00395	0.00408	CcSEcCtD
Entecavir—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00392	0.00406	CcSEcCtD
Entecavir—Leukopenia—Vinorelbine—ovarian cancer	0.00392	0.00405	CcSEcCtD
Entecavir—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00383	0.00396	CcSEcCtD
Entecavir—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00381	0.00394	CcSEcCtD
Entecavir—Abdominal pain upper—Docetaxel—ovarian cancer	0.00378	0.00391	CcSEcCtD
Entecavir—Abdominal pain—Chlorambucil—ovarian cancer	0.00371	0.00383	CcSEcCtD
Entecavir—Body temperature increased—Chlorambucil—ovarian cancer	0.00371	0.00383	CcSEcCtD
Entecavir—Renal failure—Paclitaxel—ovarian cancer	0.0037	0.00383	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.0037	0.00382	CcSEcCtD
Entecavir—Dyspepsia—Topotecan—ovarian cancer	0.00367	0.0038	CcSEcCtD
Entecavir—Gastrointestinal disorder—Topotecan—ovarian cancer	0.0036	0.00373	CcSEcCtD
Entecavir—Fatigue—Topotecan—ovarian cancer	0.0036	0.00372	CcSEcCtD
Entecavir—Dyspepsia—Melphalan—ovarian cancer	0.0036	0.00372	CcSEcCtD
Entecavir—Haematuria—Paclitaxel—ovarian cancer	0.00359	0.00371	CcSEcCtD
Entecavir—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00357	0.00369	CcSEcCtD
Entecavir—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00356	0.00368	CcSEcCtD
Entecavir—Infection—Vinorelbine—ovarian cancer	0.00355	0.00367	CcSEcCtD
Entecavir—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00353	0.00365	CcSEcCtD
Entecavir—Fatigue—Melphalan—ovarian cancer	0.00352	0.00364	CcSEcCtD
Entecavir—Nervous system disorder—Vinorelbine—ovarian cancer	0.0035	0.00362	CcSEcCtD
Entecavir—Skin disorder—Vinorelbine—ovarian cancer	0.00347	0.00359	CcSEcCtD
Entecavir—Gastrointestinal pain—Topotecan—ovarian cancer	0.00341	0.00353	CcSEcCtD
Entecavir—Asthenia—Chlorambucil—ovarian cancer	0.00336	0.00348	CcSEcCtD
Entecavir—Neutropenia—Docetaxel—ovarian cancer	0.00335	0.00346	CcSEcCtD
Entecavir—Oedema peripheral—Paclitaxel—ovarian cancer	0.00333	0.00344	CcSEcCtD
Entecavir—Body temperature increased—Topotecan—ovarian cancer	0.0033	0.00341	CcSEcCtD
Entecavir—Abdominal pain—Topotecan—ovarian cancer	0.0033	0.00341	CcSEcCtD
Entecavir—Diarrhoea—Chlorambucil—ovarian cancer	0.00321	0.00332	CcSEcCtD
Entecavir—Renal failure—Docetaxel—ovarian cancer	0.00314	0.00324	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—ovarian cancer	0.00311	0.00321	CcSEcCtD
Entecavir—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00308	0.00319	CcSEcCtD
Entecavir—Fatigue—Vinorelbine—ovarian cancer	0.00308	0.00318	CcSEcCtD
Entecavir—Immune system disorder—Paclitaxel—ovarian cancer	0.00305	0.00316	CcSEcCtD
Entecavir—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00302	0.00312	CcSEcCtD
Entecavir—Asthenia—Topotecan—ovarian cancer	0.00299	0.0031	CcSEcCtD
Entecavir—Alopecia—Paclitaxel—ovarian cancer	0.00299	0.00309	CcSEcCtD
Entecavir—Vomiting—Chlorambucil—ovarian cancer	0.00298	0.00308	CcSEcCtD
Entecavir—Mental disorder—Paclitaxel—ovarian cancer	0.00296	0.00306	CcSEcCtD
Entecavir—Malnutrition—Paclitaxel—ovarian cancer	0.00294	0.00304	CcSEcCtD
Entecavir—Asthenia—Melphalan—ovarian cancer	0.00293	0.00303	CcSEcCtD
Entecavir—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00292	0.00302	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00289	0.00298	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—ovarian cancer	0.00288	0.00297	CcSEcCtD
Entecavir—Hepatitis—Docetaxel—ovarian cancer	0.00286	0.00296	CcSEcCtD
Entecavir—Diarrhoea—Topotecan—ovarian cancer	0.00286	0.00295	CcSEcCtD
Entecavir—Abdominal pain—Vinorelbine—ovarian cancer	0.00282	0.00292	CcSEcCtD
Entecavir—Body temperature increased—Vinorelbine—ovarian cancer	0.00282	0.00292	CcSEcCtD
Entecavir—Oedema peripheral—Docetaxel—ovarian cancer	0.00282	0.00292	CcSEcCtD
Entecavir—Diarrhoea—Melphalan—ovarian cancer	0.0028	0.00289	CcSEcCtD
Entecavir—Nausea—Chlorambucil—ovarian cancer	0.00278	0.00288	CcSEcCtD
Entecavir—Dizziness—Topotecan—ovarian cancer	0.00276	0.00285	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00267	0.00276	CcSEcCtD
Entecavir—Vomiting—Topotecan—ovarian cancer	0.00265	0.00274	CcSEcCtD
Entecavir—Leukopenia—Paclitaxel—ovarian cancer	0.00263	0.00272	CcSEcCtD
Entecavir—Rash—Topotecan—ovarian cancer	0.00263	0.00272	CcSEcCtD
Entecavir—Dermatitis—Topotecan—ovarian cancer	0.00263	0.00272	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—ovarian cancer	0.00262	0.00271	CcSEcCtD
Entecavir—Headache—Topotecan—ovarian cancer	0.00261	0.0027	CcSEcCtD
Entecavir—Vomiting—Melphalan—ovarian cancer	0.0026	0.00269	CcSEcCtD
Entecavir—Immune system disorder—Docetaxel—ovarian cancer	0.00259	0.00268	CcSEcCtD
Entecavir—Rash—Melphalan—ovarian cancer	0.00258	0.00266	CcSEcCtD
Entecavir—Dermatitis—Melphalan—ovarian cancer	0.00257	0.00266	CcSEcCtD
Entecavir—Asthenia—Vinorelbine—ovarian cancer	0.00256	0.00265	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—ovarian cancer	0.00255	0.00264	CcSEcCtD
Entecavir—Alopecia—Docetaxel—ovarian cancer	0.00253	0.00262	CcSEcCtD
Entecavir—Mental disorder—Docetaxel—ovarian cancer	0.00251	0.0026	CcSEcCtD
Entecavir—Malnutrition—Docetaxel—ovarian cancer	0.00249	0.00258	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00249	0.00257	CcSEcCtD
Entecavir—Nausea—Topotecan—ovarian cancer	0.00248	0.00256	CcSEcCtD
Entecavir—Diarrhoea—Vinorelbine—ovarian cancer	0.00244	0.00253	CcSEcCtD
Entecavir—Nausea—Melphalan—ovarian cancer	0.00243	0.00251	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00242	0.0025	CcSEcCtD
Entecavir—Anaphylactic shock—Paclitaxel—ovarian cancer	0.0024	0.00248	CcSEcCtD
Entecavir—Infection—Paclitaxel—ovarian cancer	0.00239	0.00247	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—ovarian cancer	0.00237	0.00245	CcSEcCtD
Entecavir—Dizziness—Vinorelbine—ovarian cancer	0.00236	0.00244	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00236	0.00244	CcSEcCtD
Entecavir—Nervous system disorder—Paclitaxel—ovarian cancer	0.00235	0.00243	CcSEcCtD
Entecavir—Skin disorder—Paclitaxel—ovarian cancer	0.00233	0.00241	CcSEcCtD
Entecavir—Vomiting—Vinorelbine—ovarian cancer	0.00227	0.00235	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—ovarian cancer	0.00226	0.00233	CcSEcCtD
Entecavir—Rash—Vinorelbine—ovarian cancer	0.00225	0.00233	CcSEcCtD
Entecavir—Dermatitis—Vinorelbine—ovarian cancer	0.00225	0.00233	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00224	0.00232	CcSEcCtD
Entecavir—Headache—Vinorelbine—ovarian cancer	0.00224	0.00231	CcSEcCtD
Entecavir—Leukopenia—Docetaxel—ovarian cancer	0.00223	0.00231	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—ovarian cancer	0.00219	0.00226	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—ovarian cancer	0.00218	0.00225	CcSEcCtD
Entecavir—Insomnia—Paclitaxel—ovarian cancer	0.00217	0.00225	CcSEcCtD
Entecavir—Somnolence—Paclitaxel—ovarian cancer	0.00213	0.00221	CcSEcCtD
Entecavir—Nausea—Vinorelbine—ovarian cancer	0.00212	0.00219	CcSEcCtD
Entecavir—Renal failure—Epirubicin—ovarian cancer	0.00212	0.00219	CcSEcCtD
Entecavir—Dyspepsia—Paclitaxel—ovarian cancer	0.00211	0.00219	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00211	0.00218	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—ovarian cancer	0.00209	0.00216	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00208	0.00215	CcSEcCtD
Entecavir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00207	0.00214	CcSEcCtD
Entecavir—Fatigue—Paclitaxel—ovarian cancer	0.00207	0.00214	CcSEcCtD
Entecavir—Haematuria—Epirubicin—ovarian cancer	0.00205	0.00212	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00204	0.0021	CcSEcCtD
Entecavir—Anaphylactic shock—Docetaxel—ovarian cancer	0.00204	0.0021	CcSEcCtD
Entecavir—Infection—Docetaxel—ovarian cancer	0.00202	0.00209	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00201	0.00208	CcSEcCtD
Entecavir—Nervous system disorder—Docetaxel—ovarian cancer	0.002	0.00206	CcSEcCtD
Entecavir—Skin disorder—Docetaxel—ovarian cancer	0.00198	0.00204	CcSEcCtD
Entecavir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00196	0.00203	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—ovarian cancer	0.00196	0.00202	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—ovarian cancer	0.00193	0.002	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—ovarian cancer	0.0019	0.00197	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—ovarian cancer	0.0019	0.00196	CcSEcCtD
Entecavir—Abdominal pain—Paclitaxel—ovarian cancer	0.0019	0.00196	CcSEcCtD
Entecavir—Body temperature increased—Paclitaxel—ovarian cancer	0.0019	0.00196	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00188	0.00195	CcSEcCtD
Entecavir—Insomnia—Docetaxel—ovarian cancer	0.00184	0.0019	CcSEcCtD
Entecavir—Somnolence—Docetaxel—ovarian cancer	0.00181	0.00187	CcSEcCtD
Entecavir—Dyspepsia—Docetaxel—ovarian cancer	0.00179	0.00185	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—ovarian cancer	0.00179	0.00185	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—ovarian cancer	0.00176	0.00182	CcSEcCtD
Entecavir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00176	0.00182	CcSEcCtD
Entecavir—Fatigue—Docetaxel—ovarian cancer	0.00175	0.00181	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—ovarian cancer	0.00175	0.0018	CcSEcCtD
Entecavir—Asthenia—Paclitaxel—ovarian cancer	0.00172	0.00178	CcSEcCtD
Entecavir—Alopecia—Epirubicin—ovarian cancer	0.00171	0.00177	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—ovarian cancer	0.00169	0.00175	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—ovarian cancer	0.00168	0.00174	CcSEcCtD
Entecavir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00166	0.00172	CcSEcCtD
Entecavir—Diarrhoea—Paclitaxel—ovarian cancer	0.00164	0.0017	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—ovarian cancer	0.00161	0.00167	CcSEcCtD
Entecavir—Abdominal pain—Docetaxel—ovarian cancer	0.00161	0.00166	CcSEcCtD
Entecavir—Body temperature increased—Docetaxel—ovarian cancer	0.00161	0.00166	CcSEcCtD
Entecavir—Dizziness—Paclitaxel—ovarian cancer	0.00159	0.00164	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—ovarian cancer	0.00158	0.00163	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—ovarian cancer	0.00157	0.00162	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—ovarian cancer	0.00156	0.00161	CcSEcCtD
Entecavir—Vomiting—Paclitaxel—ovarian cancer	0.00153	0.00158	CcSEcCtD
Entecavir—Rash—Paclitaxel—ovarian cancer	0.00151	0.00157	CcSEcCtD
Entecavir—Dermatitis—Paclitaxel—ovarian cancer	0.00151	0.00156	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—ovarian cancer	0.00151	0.00156	CcSEcCtD
Entecavir—Headache—Paclitaxel—ovarian cancer	0.0015	0.00156	CcSEcCtD
Entecavir—Asthenia—Docetaxel—ovarian cancer	0.00146	0.00151	CcSEcCtD
Entecavir—Nausea—Paclitaxel—ovarian cancer	0.00143	0.00147	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00142	0.00147	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—ovarian cancer	0.00139	0.00144	CcSEcCtD
Entecavir—Diarrhoea—Docetaxel—ovarian cancer	0.00139	0.00144	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—ovarian cancer	0.00137	0.00142	CcSEcCtD
Entecavir—Infection—Epirubicin—ovarian cancer	0.00136	0.00141	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—ovarian cancer	0.00135	0.00139	CcSEcCtD
Entecavir—Dizziness—Docetaxel—ovarian cancer	0.00135	0.00139	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—ovarian cancer	0.00133	0.00138	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00132	0.00136	CcSEcCtD
Entecavir—Vomiting—Docetaxel—ovarian cancer	0.00129	0.00134	CcSEcCtD
Entecavir—Rash—Docetaxel—ovarian cancer	0.00128	0.00133	CcSEcCtD
Entecavir—Dermatitis—Docetaxel—ovarian cancer	0.00128	0.00133	CcSEcCtD
Entecavir—Headache—Docetaxel—ovarian cancer	0.00127	0.00132	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00127	0.00131	CcSEcCtD
Entecavir—Infection—Doxorubicin—ovarian cancer	0.00126	0.0013	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—ovarian cancer	0.00125	0.00129	CcSEcCtD
Entecavir—Insomnia—Epirubicin—ovarian cancer	0.00124	0.00128	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—ovarian cancer	0.00123	0.00128	CcSEcCtD
Entecavir—Somnolence—Epirubicin—ovarian cancer	0.00122	0.00126	CcSEcCtD
Entecavir—Nausea—Docetaxel—ovarian cancer	0.00121	0.00125	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—ovarian cancer	0.00121	0.00125	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00119	0.00123	CcSEcCtD
Entecavir—Fatigue—Epirubicin—ovarian cancer	0.00118	0.00122	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—ovarian cancer	0.00115	0.00119	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—ovarian cancer	0.00113	0.00117	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00112	0.00116	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—ovarian cancer	0.00112	0.00116	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.0011	0.00113	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—ovarian cancer	0.0011	0.00113	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—ovarian cancer	0.00109	0.00112	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—ovarian cancer	0.00109	0.00112	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00104	0.00107	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—ovarian cancer	0.001	0.00104	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—ovarian cancer	0.001	0.00104	CcSEcCtD
Entecavir—Asthenia—Epirubicin—ovarian cancer	0.000985	0.00102	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—ovarian cancer	0.000939	0.000971	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—ovarian cancer	0.000911	0.000942	CcSEcCtD
Entecavir—Dizziness—Epirubicin—ovarian cancer	0.000908	0.000939	CcSEcCtD
Entecavir—Vomiting—Epirubicin—ovarian cancer	0.000873	0.000902	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—ovarian cancer	0.000869	0.000899	CcSEcCtD
Entecavir—Rash—Epirubicin—ovarian cancer	0.000865	0.000895	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—ovarian cancer	0.000865	0.000894	CcSEcCtD
Entecavir—Headache—Epirubicin—ovarian cancer	0.00086	0.000889	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—ovarian cancer	0.00084	0.000868	CcSEcCtD
Entecavir—Nausea—Epirubicin—ovarian cancer	0.000815	0.000843	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—ovarian cancer	0.000808	0.000835	CcSEcCtD
Entecavir—Rash—Doxorubicin—ovarian cancer	0.000801	0.000828	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—ovarian cancer	0.0008	0.000827	CcSEcCtD
Entecavir—Headache—Doxorubicin—ovarian cancer	0.000796	0.000823	CcSEcCtD
Entecavir—Nausea—Doxorubicin—ovarian cancer	0.000754	0.00078	CcSEcCtD
